Lv11
100 积分 2020-07-14 加入
Palbociclib (PD0332991)—a Selective and Potent Cyclin-Dependent Kinase Inhibitor
16天前
已完结
Pharmacokinetic drug evaluation of palbociclib for the treatment of breast cancer
16天前
已完结
A unique CDK4/6 inhibitor: Current and future therapeutic strategies of abemaciclib
16天前
已完结
Ribociclib Population Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Analysis of Neutrophils in Cancer Patients
16天前
已完结
Characterization of Neutropenia in Advanced Cancer Patients Following Palbociclib Treatment Using a Population Pharmacokinetic-Pharmacodynamic Modeling and Simulation Approach
16天前
已完结
An In Vitro Model of Hematotoxicity: Differentiation of Bone Marrow-Derived Stem/Progenitor Cells into Hematopoietic Lineages and Evaluation of Lineage-Specific Hematotoxicity
1个月前
已完结
Pharmacokinetic‐pharmacodynamic (PK/PD) modelling of cotadutide effect in patients with chronic kidney disease and type 2 diabetes mellitus
2个月前
已完结
Pharmacokinetic/Pharmacodynamic Models of an Alzheimer’s Drug, Donepezil, in Rats
3个月前
已完结
Establishment and validation of a risk prediction model incorporating concentrations of linezolid and its metabolite PNU142300 for linezolid-induced thrombocytopenia
3个月前
已完结
Population pharmacokinetics of linezolid and its major metabolites PNU‐142300 and PNU‐142586 in adult patients
3个月前
已完结
皖公网安备34019202002308
